VERA THERAPEUTICS INC's ticker is VERA and the CUSIP is 92337R101. A total of 51 filers reported holding VERA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $602,349 | +81.0% | 43,935 | +111.9% | 0.00% | – |
| Q2 2023 | $332,765 | +380.0% | 20,733 | +132.1% | 0.00% | – |
| Q1 2023 | $69,320 | +299.4% | 8,933 | +895.9% | 0.00% | – |
| Q4 2022 | $17,357 | -84.6% | 897 | -83.1% | 0.00% | – |
| Q3 2022 | $113,000 | +2160.0% | 5,298 | +1241.3% | 0.00% | – |
| Q2 2022 | $5,000 | -89.4% | 395 | -80.3% | 0.00% | – |
| Q1 2022 | $47,000 | +261.5% | 2,009 | +110.1% | 0.00% | – |
| Q2 2021 | $13,000 | – | 956 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 5,450,000 | $74,719,500 | 8.73% |
| Kynam Capital Management, LP | 2,956,053 | $40,527,487 | 6.63% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 758,355 | $10,381,880 | 3.50% |
| Sofinnova Investments, Inc. | 3,467,156 | $47,534,709 | 3.00% |
| Altium Capital Management LP | 333,681 | $4,574,767 | 2.39% |
| Eversept Partners, LP | 1,478,489 | $20,270,084 | 1.72% |
| SECTORAL ASSET MANAGEMENT INC | 357,139 | $4,896,376 | 0.95% |
| Carlyle Group Inc. | 1,438,155 | $19,688,342 | 0.85% |
| Orbimed Advisors | 1,518,115 | $20,813,357 | 0.44% |
| Woodline Partners LP | 2,562,600 | $35,133,246 | 0.41% |